Named as a key player in 198 of our reports, across 33 regions and countries.
2023–2033 CAGR · estimates
| Market | Category | World 2023 | CAGR |
|---|---|---|---|
| Diabetes Management | Pharmaceuticals | $78 Bn | 7.1% |
| Sports Nutrition | OTC & Nutraceuticals | $52 Bn | 7.9% |
| Werable Healthcare Devices | Digital Health | $32.6 Bn | 19.8% |
| Protein Supplement | OTC & Nutraceuticals | $20 Bn | 7.4% |
| Alopecia areata | Healthcare Services | – | – |
| Weight Management Supplement | OTC & Nutraceuticals | – | – |
Named as key players in the same markets as Abbott (number of shared markets).
Glanbia PLC3 shared markets
Dexcom, Inc.2 shared markets
GlaxoSmithKline plc2 shared markets
PepsiCo2 shared markets
AbbVie Inc.1 shared market
Ajinomoto Co1 shared market
Allergan1 shared market
Alphabet Inc.1 shared market